Signaling of chloroquine-induced stress in the yeast Saccharomyces cerevisiae requires the Hog1 and Slt2 mitogen-activated protein kinase pathways

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 9, 2014, Pages 5552-5566

  Baranwal, Shivani ^a   Azad, Gajendra Kumar ^a   Singh, Vikash ^a   Tomar, Raghuvir S ^a  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH BHOPAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CHLOROQUINE; GLUTAMINE; GLUTATHIONE; GLYCEROL; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; HISTONE; HISTONE DEACETYLASE; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE HOG1; MITOGEN ACTIVATED PROTEIN KINASE SLT2; PROTEIN P42; PROTEIN P44; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; COPPER ZINC SUPEROXIDE DISMUTASE; HOG1 PROTEIN, S CEREVISIAE; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; P44 PROTEIN, HUMAN; SACCHAROMYCES CEREVISIAE PROTEIN; SLT2 PROTEIN, S CEREVISIAE; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER CELL LINE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL GROWTH; CELL SURVIVAL; CHROMATIN; CLONOGENIC ASSAY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FLUORESCENCE ACTIVATED CELL SORTING; FUNGUS GROWTH; G2 PHASE CELL CYCLE CHECKPOINT; HISTONE ACETYLATION; HUMAN; HUMAN CELL; NONHUMAN; OSMOTIC STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; STRESS; SYNTHESIS; UPREGULATION; WESTERN BLOTTING; YEAST CELL; ACTIVE TRANSPORT; ANTIFUNGAL RESISTANCE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEK293 CELL LINE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGICAL STRESS;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIMALARIALS; CELL LINE; CHLOROQUINE; DRUG RESISTANCE, FUNGAL; GLUTATHIONE; GLYCEROLPHOSPHATE DEHYDROGENASE; HEK293 CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTORS;

EID: 84906083461     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02393-13     Document Type: Article

References (75)

1. Boya P, Gonzalez-Polo RA, Poncet D, Andreau K, Vieira HL, Roumier T, Perfettini JL, Kroemer G. 2003. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22:3927-3936. http://dx.doi.org/10.1038/sj.onc.1206622. (Pubitemid 36819666)
2. Fan C, Wang W, Zhao B, Zhang S, Miao J. 2006. Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells. Bioorg. Med. Chem. 14:3218-3222. http://dx.doi.org/10.1016/j.bmc.2005.12.035.
3. Choi JH, Yoon JS, Won YW, Park BB, Lee YY. 2012. Chloroquine enhances the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle alteration. APMIS 120:597-604. http://dx.doi.org/10.1111/j.1600-0463. 2012.02876.x.
4. Wellems TE. 1992. Malaria. How chloroquine works. Nature 355:108-109.
5. Fox R. 1996. Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development. Lupus 5(Suppl 1):S4-S10. http://dx.doi.org/10.1177/096120339600500103. (Pubitemid 26196734)
6. Park J, Choi K, Jeong E, Kwon D, Benveniste EN, Choi C. 2004. Reactive oxygen species mediate chloroquine-induced expression of chemokines by human astroglial cells. Glia 47:9-20. http://dx.doi.org/10.1002/glia.20017. (Pubitemid 38879701)
7. Dias-Melicio LA, Calvi SA, Bordon AP, Golim MA, Peracoli MT, Soares AM. 2007. Chloroquine is therapeutic in murine experimental model of paracoccidioidomycosis. FEMS Immunol. Med. Microbiol. 50:133-143. http://dx.doi.org/10.1111/j.1574-695X.2007.00243.x. (Pubitemid 46763477)
8. Jahn B, Langfelder K, Schneider U, Schindel C, Brakhage AA. 2002. PKSP-dependent reduction of phagolysosome fusion and intracellular kill of Aspergillus fumigatus conidia by human monocyte-derived macrophages. Cell. Microbiol. 4:793-803. http://dx.doi.org/10.1046/j.1462-5822.2002.00228.x. (Pubitemid 35469667)
9. Levitz SM, Harrison TS, Tabuni A, Liu X. 1997. Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation. J. Clin. Invest. 100:1640-1646. http://dx.doi.org/10.1172/JCI119688. (Pubitemid 27425792)
10. Rolain JM, Colson P, Raoult D. 2007. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int. J. Antimicrob. Agents 30:297-308. http://dx.doi.org/10.1016/j. ijantimicag.2007.05.015. (Pubitemid 47364778)
11. Keyaerts E, Li S, Vijgen L, Rysman E, Verbeeck J, Van Ranst M, Maes P. 2009. Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice. Antimicrob. Agents Chemother. 53:3416-3421. http://dx.doi.org/10.1128/AAC.01509-08.
12. Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A. 2006. New insights into the antiviral effects of chloroquine. Lancet Infect. Dis. 6:67-69. http://dx.doi.org/10.1016/S1473-3099(06)70361-9. (Pubitemid 43138901)
13. Kim EL, Wüstenberg R, Rübsam A, Schmitz-Salue C, Warnecke G, Bücker EM, Pettkus N, Speidel D, Rohde V, Schulz-Schaeffer W, Deppert W, Giese A. 2010. Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells. Neuro-Oncol. 12:389-400. http://dx.doi.org/10.1093/neuonc/ nop046.
14. Gurova KV, Hill JE, Guo C, Prokvolit A, Burdelya LG, Samoylova E, Khodyakova AV, Ganapathi R, Ganapathi M, Tararova ND, Bosykh D, Lvovskiy D, Webb TR, Stark GR, Gudkov AV. 2005. Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors. Proc. Natl. Acad. Sci. U. S. A. 102:17448-17453. http://dx.doi.org/10. 1073/pnas.0508888102. (Pubitemid 41740886)
15. Borges MC, Castro LA, Fonseca BA. 2013. Chloroquine use improves dengue-related symptoms. Mem. Inst. Oswaldo Cruz 108:596-599. http://dx.doi.org/10.1590/S0074-02762013000500010.
16. Jiang PD, Zhao YL, Shi W, Deng XQ, Xie G, Mao YQ, Li ZG, Zheng YZ, Yang SY, Wei YQ. 2008. Cell growth inhibition, G2/M cell cycle arrest, and apoptosis induced by chloroquine in human breast cancer cell line Bcap-37. Cell. Physiol. Biochem. 22:431-440. http://dx.doi.org/10.1159/000185488.
17. Mitscher LA. 2005. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. Chem. Rev. 105:559-592. http://dx.doi.org/10. 1021/cr030101q. (Pubitemid 40351634)
18. Ben-Zvi I, Kivity S, Langevitz P, Shoenfeld Y. 2012. Hydroxychloroquine: from malaria to autoimmunity. Clin. Rev. Allergy Immunol. 42:145-153. http://dx.doi.org/10.1007/s12016-010-8243-x.
19. Melese T, Hieter P. 2002. From genetics and genomics to drug discovery: yeast rises to the challenge. Trends Pharmacol. Sci. 23:544-547. http://dx.doi.org/10.1016/S0165-6147(02)02097-7. (Pubitemid 35375795)
20. Hughes TR. 2002. Yeast and drug discovery. Funct. Integr. Genomics 2:199-211. http://dx.doi.org/10.1007/s10142-002-0059-1. (Pubitemid 41449154)
21. Huang ZW, Srinivasan S, Zhang JH, Chen KF, Li YX, Li W, Quiocho FA, Pan XW. 2012. Discovering thiamine transporters as targets of chloroquine using a novel functional genomics strategy. PloS Genet. 8:e1003083. http://dx.doi.org/ 10.1371/journal.pgen.1003083.
22. Emerson LR, Nau ME, Martin RK, Kyle DE, Vahey M, Wirth DF. 2002. Relationship between chloroquine toxicity and iron acquisition in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 46:787-796. http://dx.doi.org/10.1128/ AAC.46.3.787-796.2002. (Pubitemid 34157665)
23. Emerson LR, Skillman BC, Wolfger H, Kuchler K, Wirth DF. 2004. The sensitivities of yeast strains deficient in PDR ABC transporters, to quinoline-ring antimalarial drugs. Ann. Trop. Med. Parasit. 98:643-649. http://dx.doi.org/10.1179/000349804225021523.
24. Garrington TP, Johnson GL. 1999. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11:211-218. http://dx.doi.org/10.1016/S0955-0674(99)80028-3. (Pubitemid 29164036)
25. Hohmann S. 2002. Osmotic stress signaling and osmoadaptation in yeasts. Microbiol. Mol. Biol. Rev. 66:300-372. http://dx.doi.org/10.1128/MMBR.66.2.300- 372.2002. (Pubitemid 34625712)
26. Chen TH, Chang PC, Chang MC, Lin YF, Lee HM. 2005. Chloroquine induces the expression of inducible nitric oxide synthase in C6 glioma cells. Pharmacol. Res. 51:329-336. http://dx.doi.org/10.1016/j.phrs.2004.10.004.
27. Bermejo C, Rodriguez E, Garcia R, Rodriguez-Pena JM, Rodriguez de la Concepcion ML, Rivas C, Arias P, Nombela C, Posas F, Arroyo J. 2008. The sequential activation of the yeast HOG and SLT2 pathways is required for cell survival to cell wall stress. Mol. Biol. Cell 19:1113-1124. http://dx.doi.org/ 10.1091/mbc.E07-08-0742. (Pubitemid 351481824)
28. Azad GK, Singh V, Golla U, Tomar RS. 2013. Depletion of cellular iron by curcumin leads to alteration in histone acetylation and degradation of Sml1p in Saccharomyces cerevisiae. PLoS One 8:e59003. http://dx.doi.org/10.1371/journal. pone.0059003.
29. Azad GK, Balkrishna SJ, Sathish N, Kumar S, Tomar RS. 2012. Multifunctional Ebselen drug functions through the activation of DNA damage response and alterations in nuclear proteins. Biochem. Pharmacol. 83:296-303. http://dx.doi.org/10.1016/j.bcp.2011.10.011.
30. Shah JB, Kumar S, Azad GK, Bhakuni BS, Panini P, Ahalawat N, Tomar RS, Detty M, Kumar S. 8 January 2014. An ebselen like catalyst with enhanced GPx activity via a selenol intermediate. Org. Biomol. Chem. http://dx.doi.org/10. 1039/c4ob00027g.
31. Singh V, Azad GK, Reddy M A, Baranwal S, Tomar RS. 2 May 2014. Anti-cancer drug KP1019 induces Hog1 phosphorylation and protein ubiquitylation in Saccharomyces cerevisiae. Eur. J. Pharmacol. http://dx.doi.org/10.1016/j. ejphar.2014.04.032.
32. Singh V, Azad GK, Mandal P, Reddy MA, Tomar RS. 20 February 2014. Anti-cancer drug KP1019 modulates epigenetics and induces DNA damage response in Saccharomyces cerevisiae. FEBS Lett. http://dx.doi.org/10.1016/j.febslet.2014. 02.017.
33. Azad GK, Singh V, Mandal P, Singh P, Golla U, Baranwal S, Chauhan S, Tomar RS. 6 January 2014. Ebselen induces reactive oxygen species (ROS)-mediated cytotoxicity in Saccharomyces cerevisiae with inhibition of glutamate dehydrogenase being a target. FEBS Open Bio http://dx.doi.org/10.1016/j.fob. 2014.01.002.
34. Golla U, Singh V, Azad GK, Singh P, Verma N, Mandal P, Chauhan S, Tomar RS. 2013. Sen1p contributes to genomic integrity by regulating expression of ribonucleotide reductase 1 (RNR1) in Saccharomyces cerevisiae. PLoS One 8:e64798. http://dx.doi.org/10.1371/journal.pone.0064798.
35. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408. http://dx.doi.org/10.1006/meth.2001.1262. (Pubitemid 34164012)
36. Baro NK, Pooput C, Roepe PD. 2011. Analysis of chloroquine resistance transporter (CRT) isoforms and orthologues in S. cerevisiae yeast. Biochemistry 50:6701-6710. http://dx.doi.org/10.1021/bi200922g.
37. Islahudin F, Khozoie C, Bates S, Ting KN, Pleass RJ, Avery SV. 2013. Cell wall perturbation sensitizes fungi to the antimalarial drug chloroquine. Antimicrob. Agents Chemother. 57:3889-3896. http://dx.doi.org/10.1128/AAC.00478- 13.
38. Baro NK, Callaghan PS, Roepe PD. 2013. Function of resistance conferring Plasmodium falciparum Chloroquine resistance transporter isoforms. Biochemistry 52:4242-4249. http://dx.doi.org/10.1021/bi400557x.
39. Rahim R, Strobl JS. 2009. Hydroxychloroquine, chloroquine, and alltrans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. Anti-Cancer Drugs 20:736-745. http://dx.doi.org/10.1097/CAD. 0b013e32832f4e50.
40. Maeda T, Wurgler-Murphy SM, Saito H. 1994. A two-component system that regulates an osmosensing MAP kinase cascade in yeast. Nature 369:242-245. http://dx.doi.org/10.1038/369242a0. (Pubitemid 24154803)
41. Tamás MJ, Rep M, Thevelein JM, Hohmann S. 2000. Stimulation of the yeast high osmolarity glycerol (HOG) pathway: evidence for a signal generated by a change in turgor rather than by water stress. FEBS Lett. 472:159-165. http://dx.doi.org/10.1016/S0014-5793(00)01445-9. (Pubitemid 30224606)
42. Rep M, Krantz M, Thevelein JM, Hohmann S. 2000. The transcriptional response of Saccharomyces cerevisiae to osmotic shock. Hot1p and Msn2p/Msn4p are required for the induction of subsets of high osmolarity glycerol pathway-dependent genes. J. Biol. Chem. 275:8290-8300. http://dx.doi.org/10. 1074/jbc.275.12.8290. (Pubitemid 30180168)
43. Rep M, Reiser V, Gartner U, Thevelein JM, Hohmann S, Ammerer G, Ruis H. 1999. Osmotic stress-induced gene expression in Saccharomyces cerevisiae requires Msn1p and the novel nuclear factor Hot1p. Mol. Cell. Biol. 19:5474-5485. (Pubitemid 29339905)
44. Ferrigno P, Posas F, Koepp D, Saito H, Silver PA. 1998. Regulated nucleo/cytoplasmic exchange of HOG1 MAPK requires the importin beta homologs NMD5 and XPO1. EMBO J. 17:5606-5614. http://dx.doi.org/10.1093/emboj/17.19.5606. (Pubitemid 28445972)
45. Proft M, Mas G, de Nadal E, Vendrell A, Noriega N, Struhl K, Posas F. 2006. The stress-activated Hog1 kinase is a selective transcriptional elongation factor for genes responding to osmotic stress. Mol. Cell 23:241-250. http://dx.doi.org/10.1016/j.molcel.2006.05.031. (Pubitemid 44062368)
46. Proft M, Serrano R. 1999. Repressors and upstream repressing sequences of the stress-regulated ENA1 gene in Saccharomyces cerevisiae: bZIP protein Sko1p confers HOG-dependent osmotic regulation. Mol. Cell. Biol. 19:537-546. (Pubitemid 29018455)
47. Proft M, Pascual-Ahuir A, de Nadal E, Arino J, Serrano R, Posas F. 2001. Regulation of the Sko1 transcriptional repressor by the Hog1 MAP kinase in response to osmotic stress.EMBOJ. 20:1123-1133. http://dx.doi.org/10.1093/emboj/ 20.5.1123. (Pubitemid 32186802)
48. Albertyn J, Hohmann S, Thevelein JM, Prior BA. 1994. GPD1, which encodes glycerol-3-phosphate dehydrogenase, is essential for growth under osmotic stress in Saccharomyces cerevisiae, and its expression is regulated by the high-osmolarity glycerol response pathway. Mol. Cell. Biol. 14:4135-4144.
49. Bermejo C, Rodriguez E, Garcia R, Rodriguez-Pena JM, de la Concepcion MLR, Rivas C, Arias P, Nombela C, Posas F, Arroyo J. 2008. The sequential activation of the yeast HOG and SLT2 pathways is required for cell survival to cell wall stress. Mol. Biol. Cell 19:1113-1124. http://dx.doi.org/10.1091/mbc. E07-08-0742. (Pubitemid 351481824)
50. García R, Rodríguez-Peña JM, Bermejo C, Nombela C, Arroyo J. 2009. The high osmotic response and cell wall integrity pathways cooperate to regulate transcriptional responses to zymolyase-induced cell wall stress in Saccharomyces cerevisiae. J. Biol. Chem. 284:10901-10911. http://dx.doi.org/10.1074/jbc.M808693200.
51. Azad GK, Singh V, Tomar RS. 2014. Assessment of the biological pathways targeted by isocyanate using N-succinimidyl N-methylcarbamate in budding yeast Saccharomyces cerevisiae. PLoS One 9:e92993. http://dx.doi.org/10.1371/journal. pone.0092993.
52. Brewster JL, de Valoir T, Dwyer ND, Winter E, Gustin MC. 1993. An osmosensing signal transduction pathway in yeast. Science 259: 1760-1763. http://dx.doi.org/10.1126/science.7681220. (Pubitemid 23114664)
53. Bilsland E, Molin C, Swaminathan S, Ramne A, Sunnerhagen P. 2004. Rck1 and Rck2 MAPKAP kinases and the HOG pathway are required for oxidative stress resistance. Mol. Microbiol. 53:1743-1756. http://dx.doi.org/10.1111/j.1365-2958. 2004.04238.x. (Pubitemid 39265319)
54. Alonso-Monge R, Navarro-Garcia F, Roman E, Negredo AI, Eisman B, Nombela C, Pla J. 2003. The Hog1 mitogen-activated protein kinase is essential in the oxidative stress response and chlamydospore formation in Candida albicans. Eukaryot. Cell 2:351-361. http://dx.doi.org/10.1128/EC.2.2.351-361.2003. (Pubitemid 36562374)
55. Winkler A, Arkind C, Mattison CP, Burkholder A, Knoche K, Ota I. 2002. Heat stress activates the yeast high-osmolarity glycerol mitogen-activated protein kinase pathway, and protein tyrosine phosphatases are essential under heat stress. Eukaryot. Cell 1:163-173. http://dx.doi.org/10.1128/EC.1.2.163-173. 2002. (Pubitemid 36562393)
56. Lawrence CL, Botting CH, Antrobus R, Coote PJ. 2004. Evidence of a new role for the high-osmolarity glycerol mitogen-activated protein kinase pathway in yeast: regulating adaptation to citric acid stress. Mol. Cell. Biol. 24:3307-3323. http://dx.doi.org/10.1128/MCB.24.8.3307-3323.2004. (Pubitemid 38452075)
57. Han J, Lee JD, Bibbs L, Ulevitch RJ. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811. http://dx.doi.org/10.1126/science.7914033. (Pubitemid 24266145)
58. De Nadal E, Zapater M, Alepuz PM, Sumoy L, Mas G, Posas F. 2004. The MAPK Hog1 recruits Rpd3 histone deacetylase to activate osmoresponsive genes. Nature 427:370-374. http://dx.doi.org/10.1038/nature02258. (Pubitemid 38133666)
59. Bernstein BE, Tong JK, Schreiber SL. 2000. Genomewide studies of histone deacetylase function in yeast. Proc. Natl. Acad. Sci. U. S. A. 97:13708-13713. http://dx.doi.org/10.1073/pnas.250477697.
60. Kurdistani SK, Grunstein M. 2003. Histone acetylation and deacetylation in yeast. Nat. Rev. Mol. Cell Biol. 4:276-284. http://dx.doi.org/10.1038/ nrm1075. (Pubitemid 36383954)
61. Reiser V, Ruis H, Ammerer G. 1999. Kinase activity-dependent nuclear export opposes stress-induced nuclear accumulation and retention of Hog1 mitogen-activated protein kinase in the budding yeast Saccharomyces cerevisiae. Mol. Biol. Cell 10:1147-1161. http://dx.doi.org/10.1091/mbc.10.4.1147. (Pubitemid 29193737)
62. O'Rourke SM, Herskowitz I. 2004. Unique and redundant roles for HOG MAPK pathway components as revealed by whole-genome expression analysis. Mol. Biol. Cell 15:532-542. http://dx.doi.org/10.1091/mbc.E03-07-0521. (Pubitemid 38146471)
63. Nahas N, Molski TF, Fernandez GA, Sha'afi RI. 1996. Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP)-kinase cascade in human neutrophils stimulated with various agonists. Biochem. J. 318(Pt 1):247-253. (Pubitemid 26283653)
64. Thorsen M, Di Y, Tangemo C, Morillas M, Ahmadpour D, Van der Does C, Wagner A, Johansson E, Boman J, Posas F, Wysocki R, Tamas MJ. 2006. TheMAPKHog1p modulates Fps1p-dependent arsenite uptake and tolerance in yeast. Mol. Biol. Cell 17:4400-4410. http://dx.doi.org/10.1091/mbc.E06-04-0315. (Pubitemid 44522058)
65. Albertyn J, Hohmann S, Prior BA. 1994. Characterization of the osmotic-stress response in Saccharomyces cerevisiae: osmotic stress and glucose repression regulate glycerol-3-phosphate dehydrogenase independently. Curr. Genet. 25:12-18. http://dx.doi.org/10.1007/BF00712960. (Pubitemid 24006197)
66. Nevoigt E, Stahl U. 1997. Osmoregulation and glycerol metabolism in the yeast Saccharomyces cerevisiae. FEMS Microbiol. Rev. 21:231-241. http://dx.doi.org/10.1111/j.1574-6976.1997.tb00352.x. (Pubitemid 28018203)
67. André L, Hemming A, Adler L. 1991. Osmoregulation in Saccharomyces cerevisiae. Studies on the osmotic induction of glycerol production and glycerol-3-phosphate dehydrogenase (NAD+). FEBS Lett. 286:13-17.
68. Blomberg A, Adler L. 1989. Roles of glycerol and glycerol-3-phosphate dehydrogenase (NAD+) in acquired osmotolerance of Saccharomyces cerevisiae. J. Bacteriol. 171:1087-1092.
69. Michihara A, Toda K, Kubo T, Fujiwara Y, Akasaki K, Tsuji H. 2005. Disruptive effect of chloroquine on lysosomes in cultured rat hepatocytes. Biol. Pharm. Bull. 28:947-951. http://dx.doi.org/10.1248/bpb.28.947. (Pubitemid 40880294)
70. Islahudin F, Khozoie C, Bates S, Ting KN, Pleass RJ, Avery SV. 2013. Cell wall perturbation sensitizes fungi to the antimalarial drug chloroquine. Antimicrob. Agents Chemother. 57:3889-3896. http://dx.doi.org/10.1128/AAC.00478- 13.
71. Harrison JC, Bardes EG, Zyla TR, Lew DJ. 2002. Stress-specific activation mechanisms for the "cell integrity"MAPKpathway in Saccharomyces cerevisiae. Mol. Biol. Cell 13:294a-294a. http://dx.doi.org/10.1074/jbc. M306110200.
72. Becker K, Tilley L, Vennerstrom JL, Roberts D, Rogerson S, Ginsburg H. 2004. Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int. J. Parasitol. 34:163-189. http://dx.doi.org/10.1016/j.ijpara. 2003.09.011. (Pubitemid 38229822)
73. Loria P, Miller S, Foley M, Tilley L. 1999. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Biochem. J. 339:363-370. http://dx.doi.org/10.1042/ 0264-6021:3390363. (Pubitemid 29209967)
74. Aikawa M. 1972. High-resolution autoradiography of malarial parasites treated with 3 H-chloroquine. Am. J. Pathol. 67:277-284.
75. Yayon A, Cabantchik ZI, Ginsburg H. 1984. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J. 3:2695-2700.